Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artificial saliva gel for prevention of oral lesions in intensive care unit patients
RBR-10fqpzdgTerminated
- Sponsor
- Universidade Federal do Rio Grande do Norte
- Start
- Oct 2024
- Countries
- 1
01
Overview
Randomised, single-blind trial in xerostomia, oral candidiasis and Oral ulcer (2 arms), sponsored by Universidade Federal do Rio Grande do Norte. Primary endpoint: Prevention of oral lesions. Started Oct 2024; status: terminated.
02
Conditions
xerostomiaoral candidiasisOral ulcer
Beyond the preview
Go deeper on RBR-10fqpzdg.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-10fqpzdg.